Question.4158 - Descriptive epidemiology project submission
Answer Below:
Descriptive xxxxxxxxxxxx Project xxxxxxxxxx An xxxxxxx Analysis xx Type xxxxxxxx Mellitus x DM xxxxx KasongoMPH xxxxxxxxxx of xxxxxxxxxxxx Dr xxxxxxx Bryden xx Charlotte xxxxxxx Eastern xxxxxxxx University xxxxxxx Definition xxxxxxx resistance xxx relative xxxxxxx insufficiency xxx hallmarks xx type xxxxxxxx mellitus x DM x chronic xxxxxxxxx disease xxxx raises xxxxx glucose xxxxxx The xxxxxxxx Diabetes xxxxxxxxxxx states xxxx if xxx of xxx following xxxxxxxxxx are xxxxxxxxx type xxxxxxxx is xxxxxxxxx Plasma xxxxxxx during xxxxxxx gt xx dL xxxx L xxxxxx an xxxx glucose xxxxxxxxx test xxxxxx glucose xxxxxx must xx at xxxxx mg xx after xxxxx hemoglobin x c xxxx mol x patient xxxxxxxxxx the xxxxxxx signs xx hyperglycemia xx hyperglycemic xxxxxx has x random xxxxxx glucose xxxxx of xx mg xx mmol x Descriptive xxxxxxxxxxxx Incidence xxxxxxxxxx Diabetes xxxx is x serious xxxxxx health xxxxxxx An xxxxxxxxx million xxxxxxxxx or xxxxxxx of xxx population xxxx diabetes xxxx type xxxxxxxx making xx - xx all xxxxxxxxx cases xx claimed xx the xxxxxxx for xxxxxxx Control xxx Prevention xxx According xx the xxxxxxxxxxxxx Diabetes xxxxxxxxxx IDF xxxxxx million xxxxxxx between xxx ages xx and xxxxxxxxx have xxxxxxxx and xx the xxxxxx is xxxxxxxx to xxxxxxxx to xxxxxxx Mortality xxx of xxx main xxxxxx of xxxxx around xxx world xx diabetes xxxxxxxxx to xxx CDC xxxxxxxx accounted xxx over xxxxxx in xxx was xxx seventh xxxx cause xx death xx the xxxxxx States xxxxxxxx is xxxx to xxxx killed xxxxxx billion xxxxxx worldwide xx IDF xxxxxxxxxxx in xxxxxxxxx and xxxxxxxxx According xx Person xxxxxxxxxxxxxxx Numerous xxxxxxxx characteristics xxxxxxxxx the xxxxxxxxxx and xxxxxxxxx of xxxx diabetes xxx The xxxxxxxxxx of xxxx diabetes xxxxx adults xxxx increases xxxx age xxx Sex xxxxxxxx women xxx have xxxxxx mortality xxxxx from xxxx diabetes xxx are xxxx likely xxxx women xx develop xxx disease xxxxxx et xx Race xxxxxxxxx Compared xx Caucasians xxxxxxxx groups xxxx as xxxxxxx Americans xxxxxxxxx Native xxxxxxxxx and xxxx Asian xxxxxxxx groups xxx more xxxxxx to xxxxxxx type xxxxxxxx T xx C xx Socioeconomic xxxxxx Because xx restricted xxxxxx to xxxx healthcare xxx disease xxxxxxxxxx education xxxxxx with xxxxx socioeconomic xxxxxx are xxxx likely xx have xxxx diabetes x DM xxxxxx et xx Occupation xxxxxxxxxxx with xxx levels xx physical xxxxxxxx are xxxxxxxxxx with xxxxxxxxx incidence xxxxx of xxxx diabetes xxxxxxx et xx Differences xx Incidence xxx Mortality xxxxxxxxx to xxxxx Characteristics xxxxx vs xxxxx Research xxxxxxxx that xxxxxxx of xxxxxxxxx choices xxx easier xxxxxx to xxxxxxxxx foods xxxxx populations xxxxx have xxxxxx rates xx type xxxxxxxx than xxxxx communities xxxxxxx et xx Regional xxxxxxxxxx Due xx large xxxx to xxxxxxxxx and xxxxxxxxxxxxx variables xxxxxxxx States xx the xxxxxx States xxxx greater xxxxxxxxxx rates xx type xxxxxxxx than xxxxxxxx ones xxx Physical xxxxxxxxxxx Environmental xxxxxxxx that xxxxxx physical xxxxxxxx levels xxxxx in xxxx affect xxx incidence xx diabetes xxxxxxxxx the xxxxxxxx of xxxxx and xxxxxxxxxxxx facilities xxxxxx et xx Time xxxxxxxxxxxxxxx of xxxx Diabetes xxxxxxxx Examining xxxxxxxxxx in xxxxxxxxx and xxxxxxxxxx rates xxxxxx time xx well xx spotting xxxxxxxx in xxx diseases xxxxxx are xxxxxxxxx components xx comprehending xxx temporal xxxxxxx of xxxx Diabetes xxxxxxxx T xx Trends xx Rising xxxxxxxxxx and xxxxxxxxx Over xxxx Over xxx past xxx decades xxxxx has xxxx a xxxxxxx increase xx the xxxxxxxxxx of xxxx diabetes xxx CDC xxxxxxx that xxxxxxx persons xxxx diagnosed xxxx diabetes xx up xxxx million xx Numerous xxxxxxxxx such xx rising xxxxxxx rates xxxxxxxxx lifestyles xxx dietary xxxxxxx are xx blame xxx this xxxxx According xx a xxxxxx by xxx International xxxxxxxx Federation xxx number xx adults xxxx diabetes xxxxxxxxx has xxxx than xxxxxxx since xxxx million xx million xxxxxxxxxxxx Rates xxxx the xxxx years xxxxx have xxxx noticeable xxxxxxxxx in xxxxxxxxxxxx incidence xxxxx of xxxx diabetes xxx age-adjusted xxxxxxxxxx among xxxxxx for xxxxxxx rose xxxx in xx in xxx Increases xxxx been xxxxxxxxxxxx more xxxxxxxxxx in xxxxx age xxxxxx especially xxxxx over xxxxx is xxxxxxxxxx of xxxx a xxxxxx prevalence xx diabetes xx this xxxxx and x rapidly xxxxx population xxxxxxxxx Rates xxxxxxxxxxxxxxxx mortality xx still xxxx despite xxxxxxxxxxxx in xxxxxxxx care xxx control xxxxxxxxx to xxx CDC xxxxxxx and xxxxxxxxxxxx death xxxxx from xxxxxxxx stayed xxxxxxx unchanged xxxxxxxxxx that xxxxxxx public xxxxxx initiatives xxx necessary xxx Geographic xxxxxx Southern xxxxxx in xxx United xxxxxx consistently xxxxxx higher xxxxx of xxxx diabetes xxxxxxxx prevalence xxxxxx by xxxxxxxx The xxxxxxxxxx of xxxxxxxx has xxxxxxxxxxxxx increased xx states xxxx Mississippi xxx Alabama xxxxxxx and xxxxxx the xxxxxxxxx states xxxx reported xxxxx and xxxx steady xxxxx CDC xxxxxxxxx Future xxxxxx million xxxxxx are xxxxxxxxx to xxxx diabetes xx indicating xxxx the xxxxxxxx prevalence xxxx continue xx increase xxxxxxxxxx growth xxxxx and xxxxxx obesity xxxxx worldwide xxx some xx the xxxxxxx causing xxxx surge xxxxxxxxxx on xxx Epidemiological xxxx on xxxx Diabetes xxxxxxxx T xx A xxxxxxxx summary xx Type xxxxxxxx Mellituss x DM xxxxxxxxx prevalence xxxxxxxxx and xxxx factors xxx be xxxxx in xxx epidemiological xxxxxxxxxx The xxxxx conclusions xxx insights xxx as xxxxxxx Association xxxx Certain xxxxxxx Obesity xxx prevalence xx type xxxxxxxx is xxxxxxxx correlated xxxx obesity xxxxx Approximately xx people xxxx type xxxxxxxx are xxxxxxxxxx or xxxxx indicating xxxx obesity xx a xxxxx risk xxxxxx CDC xxxxxxxx Inactivity xxxxxxxx Inactivity xx a xxxxx risk xxxxxx for xxxx diabetes xxxxxxx sedentary xxxxxxxxxx lead xx insulin xxxxxxxxxx Socioeconomic xxxxxxxx Higher xxxxxxxxx rates xxx continuously xxxxxxxxxx with xxxxx socioeconomic xxxxxxxx indicating xxxx access xx good xxxxx healthcare xxx education xxxxx a xxxxxxx role xx the xxxxxxxxxx of xxxxxxxx Established xxxx Factors xxx As xxxxxx age xxxxxxxxxx those xxxx the xxxx rises xxxxxxxxxx Genetic xxxxxxx A xxxxxxxxx indicator xx a xxxxxxx predisposition xx diabetes xx a xxxxxx history xx the xxxxxxxxx Race xxxxxxxxx T xx is xxxx common xx several xxxxxx and xxxxxx groups xxxx as xxxxxx Americans xxxxxxx Americans xxx Hispanics xxxxxxxxx Syndrome xx elevated xxxx of xxxx diabetes xx tightly xxxxxx to xxxxxxxxxx such xx dyslipidemia xxx hypertension xxxxx et xx Consistency xxxx Established xxxx Factors xxxxxxxxxxx features xx type xxxxxxxx including xxxxxxxxxxx differences xx incidence xxx mortality xxxxx with xxxxx risk xxxxxxx For xxxxxxx the xxxxxx frequency xx minority xxxxxx is xxxxxxxxxx with xxxxxxxxxxx risk xxxxxxx associated xxxx genetics xxxxxxxxxxxxx status xxx lifestyle xxxxxxxx rising xxxxxxx among xxxxxx citizens xxxxxxx the xxxxxx that xxxxx is x major xxxxxxxxxxx to x DM xxxx Areas xx controversy xxxxxxxxxxxxx Factors xxxxxxxx obesity xxx sedentary xxxxxxxxxx are xxxxx risk xxxxxxx more xxxxxxxx is xxxxxx to xxxxx understand xxx the xxxxx environment xxxxx planning xxxxxx to xxxxx and xxxxxx determinants xx health xxxxxx the xxxxxxxxxxx of xxxx diabetes xxxxxxx Variability xxxxxxxxx concerning xxxxxxx susceptibility xxx the xxxxxxxx of xxxxxxxxxxx in xxxxxxx development xxx raised xx the xxxxxxxxx of xxxx diabetes xx people xxx do xxx exhibit xxx obvious xxxxxxxxx risk xxxxxxx Schmidt xx al xxxxxxxxxxxx for xxxxxx Health xxxxxxxxxxxxxx and xxxxxxxx Comprehending xxx demographic xxxxxxxx of xxxx Diabetes xxxxxxxx T xx facilitates xxxxxxx public xxxxxx initiatives xx areas xxxx elevated xxxxxxxxxx and xxxxx vulnerable xxxxxx Community xxxxxxxxxxx that xxxxxxx physical xxxxxxxx and xxx prevention xx obesity xxxxx be xxxxx priority xxxx allocating xxxxxxxxx especially xx cities xxxx high xxxxxxxxxx of xxxxxxxx Additionally xxxxxxxxxxx methods xxxxxx the xxxxxxxx of xxxxxxxxxx aware xxxxxxxxxx and xxxxxxxxx initiatives xxx high-risk xxxxxxxxxxx Initiatives xxxx target xxxxxxx eating xxxxxxxx in xxxxxxxx groups xxx instance xxx improve xxx efficacy xx health xxxxxxxxx Furthermore xxxxxxx observation xx diabetes xxxxxxxx and xxxxxxx aids xx the xxxxxxxxxx of xxx efficacy xx interventions xxx provides xxxxx inputs xxx enhancing xxx improving xxxxxx health xxxxxxxxx References xxxxxxxx Diabetes xxxxxxxxxxx Classification xxx Diagnosis xx Diabetes xxxxxxxxx of xxxxxxx Care xx Diabetes xxxxxxxx Care xxxxxxx for xxxxxxx Control xxx Prevention xxx National xxxxxxxx Statistical xxxxxx Estimates xxx and xxxxxxxxxxx for xxx Results xxxx the xxxxxxxxxxxxx Diabetes xxx its xxxxxxxxxxxxxx Implications xxxxxxxx Research xxx Clinical xxxxxxxxx Diabetes xxxxxxxxxx Diabetes xxxxx th xxxxxxx Diabetes xxxxxxxx and xxxxxxxx Practice xxxxxx P xxxxxx P xxxxxxxxx S xx al xxxxxx and xxxxxxxx Diabetes xxxxxxxxxx Estimates xxx and xxxxxxxxxxx for xxx Results xxxx the xxxxxxxxxxxxx World xxxxxx Organization xxxxxx Diabetes xxxxxxxMore Articles From Epidemiology
.ico)
.ico)
.ico)
.ico)
